Mark Field Biography and Net Worth

SVP and Chief Technology Officer of Insulet

Mr. Field has served as our Senior Vice President and Chief Technology Officer since July 2023. Prior, he served as Group Vice President, Software Engineering since 2019. Prior to joining Insulet, Mr. Field served as Chief Technology Officer at Thermo Fisher Scientific, among other roles, where he led a global team responsible for IoT connected device programs, cloud-based scientific services, and E-commerce. He previously served in leadership positions at Oracle Corporation for 17 years. Mr. Field holds degrees in Computer Science and Business from the University of Auckland in New Zealand.

What is Mark N. Field's net worth?: The estimated net worth of Mark N. Field is at least $3.51 million as of June 14th, 2024. Mr. Field owns 12,875 shares of Insulet stock worth more than $3,511,141 as of March 26th. This net worth evaluation does not reflect any other assets that Mr. Field may own. Additionally, Mr. Field receives an annual salary of $954,140.00 as SVP and Chief Technology Officer at Insulet. Learn More about Mark N. Field's net worth.
How old is Mark N. Field?: Mr. Field is currently 53 years old. There are 8 older executives and no younger executives at Insulet. The oldest executive at Insulet is Mr. John Wodick Kapples, Senior VP & General Counsel, who is 64 years old. Learn More on Mark N. Field's age.
What is Mark N. Field's salary?: As the SVP and Chief Technology Officer of Insulet Co., Mr. Field earns $954,140.00 per year. There are 3 executives that earn more than Mr. Field. The highest earning executive at Insulet is Dr. James R. Hollingshead Ph.D., President, CEO & Director, who commands a salary of $2,880,000.00 per year. Learn More on Mark N. Field's salary.
How do I contact Mark N. Field?: The corporate mailing address for Mr. Field and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at ir@insulet.com. Learn More on Mark N. Field's contact information.
Has Mark N. Field been buying or selling shares of Insulet?: Mark N. Field has not been actively trading shares of Insulet over the course of the past ninety days. Most recently, Mark N. Field sold 1,500 shares of the business's stock in a transaction on Friday, June 14th. The shares were sold at an average price of $199.96, for a transaction totalling $299,940.00. Following the completion of the sale, the senior vice president now directly owns 12,875 shares of the company's stock, valued at $2,574,485. Learn More on Mark N. Field's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 27,240 shares worth more than $6,358,798.63. The most recent insider tranaction occured on January, 21st when EVP Eric Benjamin sold 12,394 shares worth more than $3,470,320.00. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 1/21/2025.

Mark N. Field Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/14/2024	Sell	1,500	$199.96	$299,940.00	12,875
6/10/2024	Sell	2,131	$190.43	$405,806.33	14,375

Mark N. Field Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $272.71

$268.83

$276.13

50 Day Range

MA: $272.27

$237.06

$288.29

2 Week Range

Now: $272.71

$160.19

$289.46

Volume

958,553 shs

Average Volume

690,204 shs

Market Capitalization

$19.15 billion

P/E Ratio

47.10

Dividend Yield

N/A

Beta

1.29

Mark Field Biography and Net Worth

What is Mark N. Field's net worth?

How old is Mark N. Field?

What is Mark N. Field's salary?

How do I contact Mark N. Field?

Has Mark N. Field been buying or selling shares of Insulet?

Who are Insulet's active insiders?

Are insiders buying or selling shares of Insulet?